Dmitriev IP - Search Results

1

A tropism-modified adenoviral vector increased the effectiveness of gene therapy for arthritis.

Bakker AC, Van de Loo FA, Joosten LA, Bennink MB, Arntz OJ, Dmitriev IP, Kashentsera EA, Curiel DT, van den Berg WB. Bakker AC, et al. Among authors: dmitriev ip. Gene Ther. 2001 Dec;8(23):1785-93. doi: 10.1038/sj.gt.3301612. Gene Ther. 2001. PMID: 11803398

2

Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob.

Krasnykh V, Dmitriev I, Mikheeva G, Miller CR, Belousova N, Curiel DT. Krasnykh V, et al. J Virol. 1998 Mar;72(3):1844-52. doi: 10.1128/JVI.72.3.1844-1852.1998. J Virol. 1998. PMID: 9499035 Free PMC article.

3

An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism.

Dmitriev I, Krasnykh V, Miller CR, Wang M, Kashentseva E, Mikheeva G, Belousova N, Curiel DT. Dmitriev I, et al. J Virol. 1998 Dec;72(12):9706-13. doi: 10.1128/JVI.72.12.9706-9713.1998. J Virol. 1998. PMID: 9811704 Free PMC article.

4

A system for the propagation of adenoviral vectors with genetically modified receptor specificities.

Douglas JT, Miller CR, Kim M, Dmitriev I, Mikheeva G, Krasnykh V, Curiel DT. Douglas JT, et al. Nat Biotechnol. 1999 May;17(5):470-5. doi: 10.1038/8647. Nat Biotechnol. 1999. PMID: 10331807

5

An advanced generation of adenoviral vectors selectively enhances gene transfer for ovarian cancer gene therapy approaches.

Vanderkwaak TJ, Wang M, Gómez-Navarro J, Rancourt C, Dmitriev I, Krasnykh V, Barnes M, Siegal GP, Alvarez R, Curiel DT. Vanderkwaak TJ, et al. Gynecol Oncol. 1999 Aug;74(2):227-34. doi: 10.1006/gyno.1999.5432. Gynecol Oncol. 1999. PMID: 10419736

6

Insertion of an RGD motif into the HI loop of adenovirus fiber protein alters the distribution of transgene expression of the systemically administered vector.

Reynolds P, Dmitriev I, Curiel D. Reynolds P, et al. Gene Ther. 1999 Jul;6(7):1336-9. doi: 10.1038/sj.gt.3300941. Gene Ther. 1999. PMID: 10455445

7

Selective gene delivery to head and neck cancer cells via an integrin targeted adenoviral vector.

Kasono K, Blackwell JL, Douglas JT, Dmitriev I, Strong TV, Reynolds P, Kropf DA, Carroll WR, Peters GE, Bucy RP, Curiel DT, Krasnykh V. Kasono K, et al. Clin Cancer Res. 1999 Sep;5(9):2571-9. Clin Cancer Res. 1999. PMID: 10499635

8

Ectodomain of coxsackievirus and adenovirus receptor genetically fused to epidermal growth factor mediates adenovirus targeting to epidermal growth factor receptor-positive cells.

Dmitriev I, Kashentseva E, Rogers BE, Krasnykh V, Curiel DT. Dmitriev I, et al. J Virol. 2000 Aug;74(15):6875-84. doi: 10.1128/jvi.74.15.6875-6884.2000. J Virol. 2000. PMID: 10888627 Free PMC article.

9

Using a tropism-modified adenoviral vector to circumvent inhibitory factors in ascites fluid.

Blackwell JL, Li H, Gomez-Navarro J, Dmitriev I, Krasnykh V, Richter CA, Shaw DR, Alvarez RD, Curiel DT, Strong TV. Blackwell JL, et al. Hum Gene Ther. 2000 Aug 10;11(12):1657-69. doi: 10.1089/10430340050111313. Hum Gene Ther. 2000. PMID: 10954900

10

Advanced generation adenoviral vectors possess augmented gene transfer efficiency based upon coxsackie adenovirus receptor-independent cellular entry capacity.

Krasnykh V, Dmitriev I, Navarro JG, Belousova N, Kashentseva E, Xiang J, Douglas JT, Curiel DT. Krasnykh V, et al. Cancer Res. 2000 Dec 15;60(24):6784-7. Cancer Res. 2000. PMID: 11156365 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters